These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16674608)

  • 1. A prospective PET study of patients with glioblastoma multiforme.
    Andersen PB; Blinkenberg M; Lassen U; Kosteljanetz M; Wagner A; Poulsen HS; Sørensen PS; Paulson OB
    Acta Neurol Scand; 2006 Jun; 113(6):412-8. PubMed ID: 16674608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
    Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
    Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
    Douglas JG; Stelzer KJ; Mankoff DA; Tralins KS; Krohn KA; Muzi M; Silbergeld DL; Rostomily RC; Scharnhorst J; Spence AM
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):886-91. PubMed ID: 16242251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
    J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can an ¹⁸F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    Zhang H; Liu N; Gao S; Hu X; Zhao W; Tao R; Chen Z; Zheng J; Sun X; Xu L; Li W; Yu J; Yuan S
    J Nucl Med; 2016 Apr; 57(4):524-9. PubMed ID: 26514171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
    Lee IH; Piert M; Gomez-Hassan D; Junck L; Rogers L; Hayman J; Ten Haken RK; Lawrence TS; Cao Y; Tsien C
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):479-85. PubMed ID: 18834673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma multiforme imaging: the role of nuclear medicine.
    Alexiou GA; Tsiouris S; Voulgaris S; Kyritsis AP; Fotopoulos AD
    Curr Radiopharm; 2012 Oct; 5(4):308-13. PubMed ID: 22642425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
    Salmaggi A; Milanesi I; Silvani A; Gaviani P; Marchetti M; Fariselli L; Solero CL; Maccagnano C; Casali C; Guzzetti S; Pollo B; Ciusani E; Dimeco F
    J Neurosurg; 2013 Apr; 118(4):821-9. PubMed ID: 23350777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod.
    Lukas RV; Juhász C; Wainwright DA; James CD; Kennedy E; Stupp R; Lesniak MS
    J Neurooncol; 2019 Jan; 141(1):111-120. PubMed ID: 30415456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
    Inoue A; Nishikawa M; Ohnishi T; Yano H; Kanemura Y; Ohtsuka Y; Ozaki S; Nakamura Y; Matsumoto S; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
    World Neurosurg; 2021 Sep; 153():e76-e95. PubMed ID: 34144167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
    Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
    J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma.
    Thiele F; Ehmer J; Piroth MD; Eble MJ; Coenen HH; Kaiser HJ; Schaefer WM; Buell U; Boy C
    Phys Med Biol; 2009 Sep; 54(18):5525-39. PubMed ID: 19717889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
    Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
    Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.
    Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL
    J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
    Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG.
    Belloli S; Brioschi A; Politi LS; Ronchetti F; Calderoni S; Raccagni I; Pagani A; Monterisi C; Zenga F; Zara G; Fazio F; Mauro A; Moresco RM
    Nucl Med Biol; 2013 Aug; 40(6):831-40. PubMed ID: 23915802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.